Sun Pharmaceutical Industries

ABOUT Sun Pharmaceutical Industries

• Industry Biotechnology & Drugs
• ISIN INE044A01036
• BSE Code 524715
• NSE Code SUNPHARMA

Sun Pharmaceutical Industries Limited is a specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a range of generic formulations. It produces a portfolio of generic and specialty medicines targeting a spectrum of chronic and acute treatments. The Company’s product portfolio includes generics, branded generics, specialty, over the counter (OTC)/consumer healthcare products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and intermediates. Its OTC brands includes Faringosept , Revital, and Volini. The Company offers its products in variety of dosage forms, such as tablets, capsules, sprays, injectables, inhalers, ointments, creams and liquids. Its portfolio of specialty products, branded generics are available across 100 countries. The Company operates manufacturing sites across 6 continents.

MANAGEMENT

• C. S. Muralidharan Chief Financial Officer
• Uday Baldota Chief Executive Officer - Taro Pharmaceutical Industries Limited
• Abhay Gandhi Chief Executive Officer - North America
• Kirti Ganorkar Chief Executive Officer - India Business
• Aalok Shanghvi Executive Vice President, Head - Emerging Markets, Head - Global Generics, Research and Development, Business Development, WholeTime Director.
• Jila Breeze Executive Vice President, Global Head - Quality
• Davinder Singh Executive Vice President - Sun Global Operations
• Anil Rao Senior Vice President, Chief Information Officer
• Sapna Purohit Senior Vice President, Head of Human Resources
• Azadar Khan Senior Vice President - Corporate Relations and Corporate Social Responsibility, India Regulatory Affairs